Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II... see more

GREY:IVITF - Post Discussion

View:
Post by mindseye1 on Nov 19, 2018 9:40am

RBC

FYI. In my RBC account the US symbol has been replaced this morning with a number starting with H048...  something must be going on behind the scenes. Anyone else  see a change with their broker ??
Comment by CoreyB on Nov 19, 2018 9:44am
I haven't checked my RBC yet, but my Qtrade has them marked N/A on the Valuation tab but absolutely nothing in the ticker column on Quote tab.
Comment by Stonnecut on Nov 19, 2018 10:55am
Same here ..Can't see anything on my RBC account. Why is it taking so long?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities